Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this study is to determine if a special coating, applied to the surface of glasses can reduce the frequency and severity of migraine headaches in children and adolescents. This study is being conducted by researchers at Primary Children's Medical Center, The John Moran Eye Center, and the University of Utah Department of Electrical Engineering. The investigators have determined that a specific frequency of light is particularly bothersome to migraine patients. The coating they've developed is designed to block this frequency of light. Very few treatments are approved for the treatment of childhood migraine. The investigators hope that these glasses will provide a safe way to improve headaches in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2013
CompletedFirst Posted
Study publicly available on registry
September 16, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedResults Posted
Study results publicly available
March 26, 2020
CompletedNovember 9, 2022
November 1, 2022
4.2 years
June 14, 2013
April 12, 2019
November 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HIT-6 Score
The HIT-6 (Headache Impact Test) is a validated measure of the impact of headache on activities of daily living, functional health and well-being. The minimum score is 36 and the maximum score is 78. The higher the score, the more your headaches are adversely affecting activities of daily living. Patients who score higher than 50 are encouraged to seek help from their physician.
12 weeks
Study Arms (1)
Investigational Coating
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Must be diagnosed with migraine with aura or migraine without aura
- Must have at least 10 headache days per month
You may not qualify if:
- Currently wearing a spectacle tint specifically prescribed for migraine or light sensitivity
- Pregnant
- Unwilling or unable in the judgment of the investigator to complete the study
- Unavailable for any of the study visits
- Light sensitive conditions: meningitis, iritis, blepharospasm, albinism
- Degenerative diseases of the retina or optic nerve: diabetic retinopathy, ischemic optic neuropathy
- Medications known to affect retinal or optic nerve function: hydroxychloroquine, chloroquine, ethambutol, amiodarone, erectile dysfunction drugs
- Best corrected visual acuity less than 20/40 in either eye
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Primary Children's Hospitalcollaborator
Study Sites (1)
Moran Eye Center
Salt Lake City, Utah, 84132, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bradley Katz
- Organization
- University of Utah
Study Officials
- PRINCIPAL INVESTIGATOR
Bradley Katz, MD
University of Utah
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
June 14, 2013
First Posted
September 16, 2013
Study Start
January 1, 2014
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
November 9, 2022
Results First Posted
March 26, 2020
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share